Literature DB >> 27221629

Lipopolysaccharide-induced podocyte injury is mediated by suppression of autophagy.

Xiaofan Tan1, Yuanhan Chen1, Xinling Liang1, Chunping Yu1, Yuxiong Lai1, Li Zhang1, Xingchen Zhao1, Hong Zhang1, Ting Lin1, Ruizhao Li1, Wei Shi1.   

Abstract

High-level autophagy has an important role in maintaining the stable state of podocytes. The present study explored the influence of lipopolysaccharide (LPS) on autophagic activity in podocytes and demonstrated its mechanistic involvement in LPS-induced injury. Conditionally immortalized podocytes were cultured in vitro and were treated with chloroquine (CQ), LPS, LPS+rapamycin or LPS+3‑methyladenine (3‑MA). The autophagic vesicles and endoplasmic reticulum were observed using transmission electron microscopy. The tandem mRFP‑GFP‑LC3 adenovirus was used to detect autophagosomes and autolysosomes. The expression levels of light chain 3‑II (LC3 II), beclin‑1, P62, CCAAT‑enhancer‑binding protein homologous protein (CHOP) and podocin were determined by western blot analysis. Autophagic vesicles were detected in podocytes under basic conditions. CQ was found to increase the protein levels of LC3 II in a time‑dependent manner (2, 4 or 6 h), confirming the high activity of autophagy in podocytes. Compared with the control group, LPS induced the expansion of the endoplasmic reticulum and high expression levels of CHOP, while decreasing the protein expression of podocin. Notably, podocytes treated with LPS showed decreases in LC3 II and beclin‑1 levels and autophagosome/autolysosome numbers, which was accompanied by high P62 levels. Furthermore, the autophagy enhancer rapamycin reversed the downregulation of LC3 II and podocin, and the upregulation of CHOP induced by LPS, while the autophagy inhibitor 3‑MA aggravated the effects of LPS. In conclusion, the present study demonstrated that LPS inhibited podocyte autophagy, which contributed to LPS-induced injury of podocytes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27221629     DOI: 10.3892/mmr.2016.5301

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.

Authors:  Xingchen Zhao; Yuanhan Chen; Xiaofan Tan; Li Zhang; Hong Zhang; Zhilian Li; Shuangxin Liu; Ruizhao Li; Ting Lin; Ruyi Liao; Qianmei Zhang; Wei Dong; Wei Shi; Xinling Liang
Journal:  J Pathol       Date:  2018-04-30       Impact factor: 7.996

2.  oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.

Authors:  Yuan Chen; Zhiyi Wang; Qian Li; Lichun Yu; Yanji Zhu; Jing Wang; Shuzhen Sun
Journal:  Mol Med Rep       Date:  2020-06-30       Impact factor: 2.952

3.  Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells.

Authors:  Yue Sun; Hong Qin; Huihui Zhang; Xiangling Feng; Lina Yang; De-Xing Hou; Jihua Chen
Journal:  Food Nutr Res       Date:  2021-03-25       Impact factor: 3.894

4.  Amino acid starvation promotes podocyte autophagy through mammalian target of rapamycin inhibition and transcription factor EB activation.

Authors:  Yuanhan Chen; Xingchen Zhao; Jiaxin Li; Li Zhang; Ruizhao Li; Hong Zhang; Ruyi Liao; Shuangxin Liu; Wei Shi; Xinling Liang
Journal:  Mol Med Rep       Date:  2018-09-03       Impact factor: 2.952

Review 5.  Podocyte Autophagy in Homeostasis and Disease.

Authors:  Qisheng Lin; Khadija Banu; Zhaohui Ni; Jeremy S Leventhal; Madhav C Menon
Journal:  J Clin Med       Date:  2021-03-12       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.